EGFR and neoplasm: Thus, excluding the possibility of decorin protein core signaling via the fibroblast α2β1 integrin receptor, it is plausible that decorin is targeting the tumor cells directly by suppressing EGFR and Met signaling (or is integrated over several receptors), and thereby functions as a paracrine agent to elicit changes within the surrounding tumor stroma.